11月10日，第八届中国国际进口博览会在上海落下帷幕。本届进博会意向成交金额达834.9亿美元，较 上届增长4.4%，创下历史新高。来自138个国家和地区的4108家企业参展，其中世界500强和行业龙头 企业达290家，充分展现了中国超大规模市场的强大"磁吸力"。 本届进博会共发布461项新产品、新技术、新服务，其中全球首发201项、亚洲首展65项、中国首秀195 项。 在这些创新成果背后，一个显著趋势正在形成：跨国企业不再仅仅将中国视为销售市场或制造基地，而 是加速推进以"中国原创"为核心的深度本土化。为此，一批外资企业调整了组织架构，以加大中国区域 对其全球市场的影响力。 外企进化：围绕创新的深度本土化 进博会会场内，多家外企提及了过去几年围绕在华发展的一系列的调整和改革，比如提升中国区域的决 策权，加大对中国供应链的投入以及推进在华创新中心的建设。 以汽车行业为例，随着中国在新能源汽车领域形成全产业链优势，越来越多海外汽车企业推出了"深耕 中国，服务中国"战略，并围绕中国产业链构建了全球化合作新模式，中国团队不仅获得产品主导权， 更在核心技术路线上拥有话语权。医药领域也呈现这一趋势。随着中国创新药产业能 ...

Core Viewpoint - The article discusses the challenges faced by major medical device companies, specifically Philips, GE Healthcare, and Siemens Healthineers (collectively referred to as GPS), in the Chinese market and globally due to trade wars and increasing competition. The companies are focusing on localization and adapting their strategies to navigate these challenges effectively [1][3][5]. Group 1: Market Challenges - In 2024, Philips experienced a double-digit revenue decline in the Chinese market, a trend mirrored by GE Healthcare and Siemens Healthineers [1][5]. - The trade war has significantly impacted GPS, with GE Healthcare estimating a loss of approximately $380 million due to tariffs by 2025, while Philips anticipates losses between €250 million to €300 million [4][5]. - The overall market environment is characterized by intensified competition, price pressures, and the need for strategic adaptation in response to new tariffs [5][14]. Group 2: Localization Efforts - Philips has achieved over 95% of its products being manufactured locally in China, positioning the country as a key supply chain and manufacturing hub [7][8]. - GE Healthcare emphasizes the importance of localizing every component, not just the equipment, to enhance supply chain resilience and quality [9][10]. - Both companies recognize the necessity of building local ecosystems and training talent to support their localization strategies [10][11]. Group 3: Competitive Landscape - Local Chinese companies like United Imaging, Neusoft, and Mindray are emerging as strong competitors, moving beyond imitation to innovation and price competition [14]. - The growing demand for healthcare solutions in China, driven by an aging population and increasing chronic diseases, presents ongoing market opportunities for GPS [14][15]. - The companies are adapting their strategies to focus on specific market segments rather than attempting to cover all areas, indicating a more targeted approach to competition [15].

Core Insights - Philips is facing significant challenges in the Chinese market, with a double-digit revenue decline reported in 2024, coinciding with the appointment of a new president for the Greater China region [1][4] - The global medical device market, particularly for major players like GE Healthcare, Siemens Healthineers, and Philips (collectively referred to as GPS), is under pressure due to trade wars and tariffs, impacting their financial performance [3][6] - The need for localization and supply chain resilience is emphasized, with Philips aiming for over 95% of its products to be manufactured locally in China, despite some core components still being imported [8][9] Market Performance - In 2024, GE Healthcare's revenue in China declined by 15%, while Siemens Healthineers reported a 14% drop in the same period, indicating a broader trend of revenue challenges among GPS companies in the region [5][12] - Philips anticipates continued revenue decline in the Chinese market into 2025, projecting a mid-single-digit percentage drop [4][12] Strategic Responses - Philips is focusing on increasing localization and integrating into the Chinese ecosystem, with plans to enhance local production capabilities and reduce reliance on imports [8][10] - The company has appointed a new Chief Competitiveness Officer to drive innovation and improve product competitiveness in response to local market dynamics [12][14] Competitive Landscape - Local Chinese medical device companies are emerging as strong competitors, with firms like United Imaging, Neusoft Medical, and Mindray gaining traction and challenging established players [12][14] - The competitive environment is expected to intensify, with price pressures and increased competition being common challenges faced by all GPS companies [6][12] Future Outlook - The Chinese market is viewed as a significant growth opportunity due to its large population and increasing healthcare demands, particularly in chronic disease management [12][13] - Despite current challenges, the long-term outlook for the medical device industry in China remains positive, with companies encouraged to adapt and innovate to meet evolving market needs [13][14]